Aurinia Pharmaceuticals Inc. 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001600620-26-000017
- Form type
- 10-K
- CIK
- 0001600620
- Primary document
- https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aurinia Pharmaceuticals Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $283.1M | - | - |
| Cost Of Revenue | $32.7M | - | - |
| Operating Income | $104.9M | - | - |
| Net Income | $287.2M | - | - |
| Eps Basic | 2.14 | - | - |
| Eps Diluted | 2.07 | - | - |
| Cash And Equivalents | $80.2M | - | - |
| Total Assets | $751.6M | - | - |
| Total Liabilities | $170.3M | - | - |
| Shareholders Equity | $581.3M | - | - |
| Operating Cash Flow | $135.7M | - | - |